Nuvectis Pharma, Inc. (NVCT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$9.50M2022: -$13.56M2023: -$15.95M2024: -$12.25M2025: -$16.01M-$16.01M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$16.01M-30.7%
2024-$12.25M+23.2%
2023-$15.95M-17.7%
2022-$13.56M-42.7%
2021-$9.50M